Results of a pilot study involving part of the results of this study were presented at the BSAVA Congress 2012, Birmingham, UK.
Assessment of Clinical and Laboratory Variables as a Guide to Packed Red Blood Cell Transfusion of Euvolemic Anemic Dogs
Article first published online: 13 JAN 2014
Copyright © 2014 by the American College of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Volume 28, Issue 2, pages 576–582, March/April 2014
How to Cite
Kisielewicz, C., Self, I. and Bell, R. (2014), Assessment of Clinical and Laboratory Variables as a Guide to Packed Red Blood Cell Transfusion of Euvolemic Anemic Dogs. Journal of Veterinary Internal Medicine, 28: 576–582. doi: 10.1111/jvim.12280
This study was performed at the University of Glasgow Small Animal Hospital, School of Veterinary Medicine, Bearsden Road, Glasgow, UK
- Issue published online: 15 MAR 2014
- Article first published online: 13 JAN 2014
- Manuscript Accepted: 18 NOV 2013
- Manuscript Revised: 6 OCT 2013
- Manuscript Received: 21 MAY 2013
- Objective clinical assessment;
- Venous oxygen content
There are no standardized guidelines for determining the likelihood that euvolemic anemic dogs will benefit from transfusion of packed red blood cells (pRBC).
To report clinical and laboratory variables of dogs receiving pRBC transfusion, which could guide transfusion of other anemic dogs.
Twenty-four client-owned anemic dogs receiving pRBC transfusion.
Prospective study; 30 transfusions assessed. Clinical findings (mucosal color, pulse quality, heart rate, respiratory rate, mentation/exercise tolerance) before and after transfusion were evaluated by the anemic dog clinical assessment score (ADCAS). Hemoglobin concentration, hematocrit, venous oxygen content (CvO2), and lactate concentration were measured from blood samples taken before and after transfusion. These results were not used for case management.
All ADCAS variables decreased significantly with transfusion (P < .001); the total score was ≥5/12 before transfusion, and ≤3/12 in all cases that were deemed to no longer require transfusion. Hematocrit and CvO2 were <17% and <5 mL/dL, respectively, in 83% of cases before transfusion and hemoglobin concentration was <5.8 g/dL in 80%. Hemoglobin concentration, hematocrit, and CvO2 increased significantly with transfusion (P < .001); lactate concentration decreased significantly (P = .006).
Conclusions and Clinical Importance
Clinical and laboratory variables improved significantly after transfusion of pRBC. By identifying how transfusion affected these variables, it was possible to recognize clinical (ADCAS) and laboratory (hemoglobin, CvO2, lactate) variables, which could be useful in guiding the decision to transfuse dogs with similar presentations.